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Exquisite control of biological function is achieved via
tight regulation of the catalytic and binding activities of
cellular proteins. The mechanistic details of protein regulation
vary from targeted chemical modification of amino acid side
chains (1) to the quite drastic global unfolding of an entire
polypeptide chain (2). Peptidyl prolyl cis/trans isomerization
is emerging as a potentially general mechanism for the
control of protein function (3). While most structures of
native, folded proteins reveal peptidyl-prolyl imide bonds
that adopt either the cis or trans conformation, there are a
growing number of folded proteins that exhibit conforma-
tional heterogeneity about one or more peptidyl-prolyl
bonds. Unlike covalent modification or global unfolding,
proline isomerization is an intrinsic conformational exchange
process that has the potential to direct ligand recognition and
to control protein activity within the confines of the native
state.
Proline is the only naturally occurring amino acid for
which both the cis and trans peptide bond conformations are
thermodynamically feasible (4, 5) lending the proline-
containing polypeptide backbone the remarkable ability to
populate discrete conformational and dynamic states sepa-
rated by a modest interconversion activation energy. Avail-
able data for short proline containing peptides indicate that
prolyl isomerization proceeds via a one-step mechanism
involving a planar transition state (6, 7) (Figure 1A). The
barrier to interconversion between the cis and trans imide
bond conformers is 14-24 kcal/mol, and the slow rate of
exchange between conformers arising from this energy
barrier (8) manifests itself as a rate-limiting step in protein
folding (9-11). A subject that has received significantly less
attention in the literature to date is the occurrence of
peptidyl-prolyl cis/trans isomerization in the context of the
native state of a folded protein. This review will discuss the
role of proline isomerization-induced conformational het-
erogeneity and its significance in controlling the binding and
function of globular proteins. The role of proline in signaling
via transmembrane R helices has recently been reviewed
elsewhere (12).
Experimental Detection of Proline Isomerization. Proline
cis/trans isomerization likely occurs in many folded proteins,
and it is possible that proline-mediated conformational
exchange events control important functions of numerous
well-studied systems, but have thus far eluded detection.
Direct identification of proline switches is challenging, as
the isomerization itself is invisible to most biochemical
methodologies. Nuclear magnetic resonance (NMR) spec-
troscopy is the best available method for direct detection of
cis/trans prolyl isomerization in a folded protein (13). With
respect to the NMR chemical shift time scale, peptidyl-
prolyl cis/trans isomerization is slow, and therefore two
resonance frequencies are observed in NMR spectra per
nuclear spin in the proximity of the isomerizing bond (Figure
1B). Characteristic NOE patterns readily discriminate the
resonances arising from the cis and trans conformers allowing
specific assignment of each substate (Figure 1C). The relative
populations of the cis and trans forms can be determined by
integration of the separate peak volumes and under the
appropriate conditions the rate of exchange between con-
formers can be measured (14). In addition to NMR spec-
troscopy, direct detection of peptidyl-prolyl cis/trans isomer-
ization within short peptides can be achieved by monitoring
changes in the ultraviolet (UV) absorbance following a rapid
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change in pH (15). The range of pH change required to alter
the cis/trans ratio is large and therefore impractical for
application of this approach to native folded proteins. As
well, reversed-phase liquid chromatography has been used
as a diagnostic for cis/trans isomerization within dipeptides
(16, 17). The applicability of this technique to native proteins
that harbor prolyl isomerization has not been demonstrated.
While NMR is the most direct method for detection of
prolyl isomerization in native proteins and peptides, protein
structures solved by X-ray crystallography can also reveal
structural heterogeneity (18). Often, a cis conformation is
apparent under certain crystallization conditions, while the
same imide bond may adopt the trans conformation when
the protein is crystallized under different conditions. The
observation of two prolyl imide bond conformations in a
crystal structure is therefore somewhat fortuitous. There are
likely many protein structures that are biased by the
crystallization process favoring a single imide bond con-
former, thereby obscuring potentially important conforma-
tional heterogeneity. Moreover, the frequent occurrence of
proline residues in flexible loops means that, for the region
of interest, many crystal structures may not be of sufficient
resolution to provide evidence for proline isomerization.
Proline Isomerization Is Catalyzed by SeVeral ConserVed
Families of Isomerases. The slow interconversion between
cis and trans prolyl imide bond conformers is catalyzed by
the peptidyl-prolyl cis/trans isomerases (PPIases). The
PPIases (namely, the cyclophilins (Cyp), FK506 binding
proteins (FKBPs) (19-21), and the parvulins (22)) bind and
stabilize a transition state that is characterized by partial
rotation around the C-N imide bond (23). The energetic
cost of distortion is compensated by favorable interactions
between enzyme and transition state. The ubiquitous nature
of these enzymes and the existence of three distinct families
of PPIases underscores the importance of proline isomer-
ization in protein structure and function. Cyclophilin A and
FKBP-12 have attracted significant attention as the protein
targets of the immunosuppressive agents cyclosporine A
(CsA) and FK-506, respectively (24). These small molecules
inhibit PPIase activity and block T cell activation. Unexpect-
edly, the immunosuppressant activity of these small mol-
ecules derives not from inhibition of isomerase activity, but
rather from interruption of signaling events by the inhibitor-
PPIase complexes themselves (25-27). Thus, while CsA and
FK506 have shed considerable light on the signal transduc-
tion pathways involved in T cell signaling, the normal cellular
roles of the PPIases remain unclear.
Functional Roles of the PPIases. The PPIases accelerate
protein folding in vitro by catalyzing the rate-limiting
peptidyl-prolyl isomerization step, implying a role for these
enzymes as folding catalysts (28-31). There is also ac-
cumulating evidence that the PPIases modulate intracellular
signaling events (32, 33). The most recently described family
of PPIases, the parvulins (22), are in fact the only members
of the PPIase superfamily that are essential for cell growth.
The prototypical parvulin, Pin1, interacts with target proteins
in a phosphorylation-dependent manner (34, 35) and is
required for normal progression through mitosis (22). Despite
the picture that is forming for the biological importance of
Pin1 isomerase activity (36), an understanding of the
physiological role of the cyclophilins and FKBPs and the
specific nature of their respective protein targets is still
lacking.
In contrast to studies involving short peptide model
substrates, the catalytic action of PPIases on folded protein
substrates has not yet been extensively studied at the
molecular level. An exception is the amino-terminal core
domain of the human immunodeficiency virus-type 1 (HIV-
1) capsid protein. The interaction between HIV-1 capsid and
cyclophilin A is essential for the subsequent packaging of
multiple copies of CypA into each HIV-1 virion (37-40).
While the precise function of CypA in HIV virulence is not
yet known and the isomerase activity of CypA per se may
not be required for HIV replication (41), virions lacking
CypA (either by interruption of the interaction with cy-
closporin or by mutations in the amino-terminal core domain)
are less infectious (39, 42).
The molecular details of the HIV-1 capsid/cyclophilin A
interaction emerged in 1996 when the three-dimensional
structure of the HIV-1 capsid protein (Figure 2A) was solved
by multidimensional heteronuclear magnetic resonance
spectroscopy (43). Shortly thereafter, the crystal structure
of human cyclophilin A bound to the amino-terminal domain
of HIV-1 capsid (Figure 2B) was reported (44). Together,
these structures provide valuable insight into the nature of a
FIGURE 1: (A) Cis/trans isomerization of an Xaa-Pro imide bond
(where Xaa is any amino acid) progresses through a planar transition
state. (B) Selected region of a 1H-15N heteronuclear single quantum
coherence spectrum of a folded protein that contains a conforma-
tionally heterogeneous proline. The circled resonances correspond
to a single backbone amide NH group and are doubled due to the
slow rate of cis/trans isomerization. Integration of cross-peak
volumes indicates that the trans/cis ratio is 60/40 for this protein.
Residues that give rise to only a single resonance (not circled) are
unaffected by the isomerization. (C) Short 1H-1H distances (NOEs)
between the CRH proton of the residue preceding proline and the
Pro CRH proton are diagnostic of the cis conformation, while the
NOE between the CRH proton of the residue preceding proline
and the Pro CäH proton are diagnostic of the trans conformation.
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physiological cyclophilin A substrate as well as the mode
of recognition between cyclophilin A and the folded capsid
protein. Two features are especially noteworthy. First, the
NMR structure of the capsid protein alone reveals that the
exposed loop that serves as the binding site of cyclophilin
A includes a single conformationally heterogeneous proline
residue (Pro 90, Figure 2A). The less populated conformer
(14%) corresponds to the protein containing the cis prolyl
imide bond at position 90, while the major species in solution
(86%) is the trans imide bond-containing conformer. The
low population of the cis imide bond-containing conformer
prohibited detailed structural analysis of that substate, and
the reported NMR structure consequently corresponds to the
trans form of the domain. Second, the structure of the
cyclophilin A-capsid complex reveals that Pro 90 adopts
exclusively the trans conformation upon binding to cyclo-
philin A (Figure 2B) in contrast to the previously solved
structures of cyclophilin A bound to short peptides where
the prolyl imide bond adopts the cis conformation (45-48).
Very recently, a series of crystal structures of CypA
complexed to several sequence variants of the HIV-1 capsid
protein were solved and reveal that the cis conformation can
also be accommodated in the CypA active site (49). In
conjunction with NMR dynamics data (50), these structures
are providing critical insight into the mechanism of prolyl
isomerization by cyclophilin A. However, it is unclear
whether the primary role of cyclophilin A is an enzyme in
vivo or instead as a protein binding module that mediates
specific protein-protein interactions (51). While the static
structures of the HIV-1 capsid-cyclophilin A complex do
not resolve this issue, more recent work by Kern and co-
workers using NMR exchange spectroscopy indicates that
cyclophilin A has the capacity to accelerate isomerization
of the Gly 89-Pro 90 imide bond within the HIV-1 capsid
protein substrate in vitro (52). Nevertheless, the extent to
which catalysis is important for the biological functions of
the cyclophilins remains to be determined. As a step toward
this goal, Kern and co-workers describe mutations within
cyclophilin A that retain binding but abolish catalysis of the
Gly 89-Pro 90 imide bond of HIV-1 capsid (52). These and
other such mutants will be invaluable in future experiments
aimed at dissecting the respective contribution of binding
and catalysis to cyclophilin A function in vivo.
Proline Isomerization Leads to a Range of Structural
Consequences in Folded Proteins. Notably, proline isomer-
ization has a minimal effect on the overall structure of the
amino-terminal domain of HIV-1 capsid. The NMR data for
the free HIV-1 capsid protein reveal doubled resonances for
only 4 of the 151 residues that comprise the domain: Ala
88, Gly89, Pro 90, and Ile 91 (43). This shows that the
structural perturbations associated with proline isomerization
are very localized. There are in fact numerous examples of
local conformational heterogeneity within folded proteins
induced by proline isomerization (53-64). One of the first
such proteins to be extensively characterized is staphylo-
coccal nuclease. NMR studies show that two interconverting
folded forms of staphylococcal nuclease coexist in solution
(65, 66) and that isomerization about the prolyl imide bond
at position 117 is the source of the observed conformational
heterogeneity (67). A more recent example of the coexistence
of alternative prolyl conformers in similar folded structures
is reported for Tendamistat (68). For this protein, kinetic
characterization of refolding reveals a nativelike state that
interconverts to native Tendamistat via proline isomerization.
In this case, cyclophilin accelerates the rate of proline
isomerization and therefore favorably affects the intercon-
version rate between the nativelike and native states of
Tendamistat. These results provide indirect evidence that
Tendamistat serves as a folded protein substrate of cyclo-
philin. For the majority of conformationally heterogeneous
FIGURE 2: (A) Overlay of 17 low energy structures of the trans conformation of the HIV-1 capsid protein as determined by NMR spectroscopy
(pdb: 1GDS). Pro 90 (yellow) is conformationally heterogeneous within the context of the folded HIV-1 capsid protein and is located at
the apex of a disordered loop. (B) The first crystal structure of the HIV-1 capsid protein bound to the active site of cyclophilin A (pdb:
1AK4). Cyclophilin A is shown as a transparent surface over the backbone trace (light blue), while only the backbone trace of the HIV-1
capsid protein (dark blue) is represented. In this structure, the imide bond preceding Pro 90 (ball-and-stick representation) exclusively
adopts the trans conformation upon binding to cyclophilin A. The residues adjacent to Pro 90 and Pro 90 itself within HIV-1 capsid are
shown in red. All structures were created in MolMol (87).
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native proteins, evidence for interactions with the PPIases
is currently lacking (69). Thus, until additional folded protein
substrates for the PPIases are identified and characterized it
is not yet clear whether the presence of a conformationally
heterogeneous proline in a folded protein is a recognition
motif for cyclophilin and/or related enzymes. In fact, it is
likely that proline isomerization itself plays an important
functional role that is independent of the action of the
peptidyl-prolyl isomerases.
Several specific proteins will now be considered to explore
the notion that a drastic structural rearrangement induced
by peptidyl-prolyl isomerization can serve as an intrinsic
molecular switch that controls protein function. In each case,
three-dimensional structures of both imide bond-containing
conformers are available, the structural consequences of the
isomerization are pronounced, and in some cases the cis and
trans conformers have been ascribed distinct functional roles.
Undoubtedly, as additional protein structures are solved and
as new methods are developed to detect native state proline
isomerization, the list of proteins known to exist in multiple
native-state conformations that differ with respect to the
isomerization state around one or more prolyl imide bonds
will grow. Ultimately, characterization of such conforma-
tionally heterogeneous proteins will provide the information
that is needed to understand both the molecular determinants
that favor dual imide bond conformers within a folded
protein, as well as the role of proline isomerization as a
molecular switch that has the potential to mediate conformer-
specific ligand binding and/or function.
NatiVe-State Proline Isomerization Causes ExtensiVe
Structural Rearrangements: Itk SH2 Domain. The nonre-
ceptor tyrosine kinase, interleukin-2 tyrosine kinase (Itk),
participates in the intracellular signaling events leading to T
cell activation (70, 71). In an effort to elucidate the
mechanism by which the catalytic activity of Itk and related
tyrosine kinases is controlled during signaling, detailed
structural analyses of the noncatalytic regulatory domains
have been carried out (72-74). Of particular importance in
the context of this review is the structure determination of
the Src homology 2 (SH2) domain of Itk (75). The Itk SH2
domain exhibits a hallmark indicator of multiple conforma-
tions in slow exchange: the appearance of “extra” resonances
in the NMR spectra. Cis/trans isomerization about the imide
bond between Asn 286 and Pro 287 within the SH2 domain
is the source of this conformational heterogeneity as mutation
of Pro 287 to Gly leads to greatly simplified spectra
consistent with a single species in solution (33).
Itk is also a physiological substrate of cyclophilin A as
the interaction between these two proteins has been detected
in T cells and cyclophilin A activity regulates Itk catalytic
function both in vitro and in vivo (33). However, the detailed
structural insights that have been reported for the HIV-1
capsid-cyclophilin A complex (52) are not yet available for
the Itk-cyclophilin A complex, and so the molecular details
of this interaction are not known. Nevertheless, proline
isomerization within the Itk SH2 domain has pronounced
structural and functional consequences that are independent
of the association with cyclophilin A. Interestingly, the
conformational heterogeneity arising from proline isomer-
ization within the Itk SH2 domain differs from the confor-
mationally heterogeneous proteins cited above. First, proline
isomerization causes long-range structural perturbations
within the Itk SH2 domain rather than the limited structural
heterogeneity observed, for example, in structural studies of
the HIV-1 capsid protein. Second, the population of the cis
and trans imide bond-containing conformers is nearly equal
(40% cis, 60% trans) as determined by integration of NMR
peak volumes permitting detailed structural investigations
of both species in solution.
NMR derived structural models for the cis and trans imide
bond-containing SH2 conformers are shown in Figure 3A.
The overall fold of the domain matches those of previously
solved SH2 domains. The conformationally heterogeneous
Pro 287 is located at the carboxy-terminus of the CD loop.
In the trans form of the domain, the CD loop extends away
from the body of the domain. Upon isomerization to the cis
form, the CD loop bends down at two hinge points located
at Pro 287 itself and at Lys 280 located directly across the
loop structure. Moreover, proline isomerization from trans
to cis affects the dynamics of the loop. Backbone dynamics
measurements (15N T1, T2, and heteronuclear ({1H}-15N)
NOE) indicate significant mobility in the trans form of the
CD loop (75) as expected for a large surface loop. In contrast
to the trans form, backbone dynamics measurements indicate
significantly less mobility for the CD loop residues in the
cis form (75). Consistent with the pronounced change in the
conformational preference and dynamics of the CD loop, the
resonance frequency differences between the cis and trans
forms are largest for the residues in the CD loop. Nonde-
generate cis and trans chemical shifts are, however, not
confined to the proline-containing loop and in fact extend
across one-third of the domain surface (Figure 3B). In
addition to the large displacement of the CD loop, statistically
significant structural differences are apparent between the
refined structures of the cis and trans forms of the Itk SH2
domain in the AB and BG loops, the top of the central â
sheet and the top turn of â helix (Figure 3C) (75).
The structural and dynamic differences that arise from
isomerization about the Asn 286-Pro 287 imide bond confer
conformer-specific properties to this domain. The Itk SH2
domain binds to two distinct ligands. In the canonical fashion,
the domain binds a phosphotyrosine containing peptide
(Figure 4A). Phosphopeptide binding occurs preferentially
with the trans form of the domain (33). The Itk SH2 domain
also forms a novel and specific intermolecular complex with
the Src homology 3 (SH3) domain of Itk (73). This
interaction favors the cis form of the SH2 domain (Figure
4B) (33). Thus, proline cis/trans isomerization and the
concomitant structural rearrangements within the SH2 do-
main serve as a molecular switch governing ligand recogni-
tion. Elucidation of the mechanism by which this occurs must
await further characterization of the structures and dynamics
of the respective complexes. Nevertheless, this example
makes clear that proline isomerization is sufficient to alter
the ligand-binding surface of a protein to an extent that can
be exploited by incoming ligands.
MS2 Capsid. A comparison of the cis and trans Itk
structures with other proteins in which a proline residue
adopts both the cis and trans imide bond conformations
suggests that the conformer-specific structural rearrangements
that have been characterized for Itk may be a general
phenomenon in controlling protein-protein interactions. A
striking example is found in the subunits of the bacteriophage
MS2 coat protein (76). The icosahedral virus bacteriophage
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MS2 is comprised of 180 copies of a coat protein surrounding
a single-stranded RNA. The structure of bacteriophage MS2
has been solved at 2.8 Å resolution (Figure 5) (77). The fold
of the MS2 coat protein differs from that of other viral coat
proteins and contains a five-stranded â-sheet, two nearly
perpendicular shorter strands and a bent helix. Furthermore,
MS2 lacks the terminal polypeptide segment that in other
viruses mediates assembly of the viral coat by switching
between ordered and disordered forms (78). Instead, the MS2
coat protein contains a conformationally heterogeneous loop
(the FG loop) that appears to fulfill a similarly critical role
in regulating assembly (77, 79). Interestingly, cis/trans
isomerization around the imide bond preceding Pro 78 is
responsible for conferring two distinct conformations to this
region of the protein (77).
Three structurally independent coat protein subunits (A-
C) are shown in Figure 5A. Each monomeric subunit is a
chemically equivalent 13.7 kDa protein. An overlay of the
three subunits reveals large conformational differences
between monomer B and monomers A and C in the region
of the proline-containing FG loop (Figure 5B) (77). The cis
imide bond in the B subunit leads to a bend in the FG loop
toward the short â-strands of the protein (Figure 5C). A
number of hydrogen bonds stabilize this conformation (77),
and it is interesting to note that in a manner similar to Itk,
a kink at the cross strand residue (Thr 69) accompanies
isomerization to the cis proline. Indeed, the structural
differences between the cis and trans prolyl bond-containing
proteins are strikingly similar for MS2 and Itk. Moreover,
as observed for Itk, dynamic differences between the cis and
trans MS2 conformers are apparent in a comparison of the
temperature factors for the residues of the FG loop. As
observed for Itk, it is the cis imide bond containing structure
that is less flexible than the corresponding trans form (77).
Candida rugosa Lipase. In a manner similar to Itk and
MS2, a functionally relevant loop rearrangement driven by
proline isomerization occurs in Candida rugosa lipase.
Crystal structures of the “open” and “closed” forms of this
enzyme have been solved to 2.06 and 2.1 Å resolution,
respectively (80, 81). The two crystal forms differ with
respect to the conformation of a single loop or “flap” region
that in the “open” form (81) protrudes away from the surface
of the enzyme allowing access to the active site and in the
“closed” form (80) makes extensive hydrophobic contacts
to the rest of the protein and shields the active site from
solvent (Figure 6A). The rearrangement between “open” and
“closed” forms involves trans to cis prolyl isomerization (Pro
92) and a concomitant bending at a hinge point across the
loop (Glu 66). The C. rugosa lipase loop (26 residues) is
significantly longer than that of Itk and MS2 and adopts
distinct secondary structure in both forms. The energetically
more stable trans prolyl imide bond is adopted in the “open”
form, while the “closed” form contains the cis conformation
(Figure 6B,C).
Is there a Motif Common to Proline Switches? It is
interesting to note that in each of the examples of native
state proline isomerization (Itk, MS2, and lipase), the trans
form corresponds to the more extended, solvent-exposed loop
conformation, while the cis form bends down. In each case,
more extensive contacts are present between the loops in
the cis prolyl imide bond conformation and the body of the
protein than in the corresponding trans conformation. Whether
hydrophobic or hydrophilic in nature, such contacts likely
provide the necessary stabilization energy to favor the
inherently less stable cis conformer. In fact, studies that have
directly compared the cis/trans ratio of a proline residue in
the context of the folded protein with that of a corresponding
FIGURE 3: (A) Ribbon diagrams of the energy minimized average
structures of the trans (left) and cis (right) Itk SH2 conformers
(pdb: 1LUN, 1LUK). Pro 287 in the CD loop and the preceding
imide bond is highlighted in red in each case. (B) Solvent-accessible
surface plot of the trans (left) and cis (right) SH2 domain. For each
structure, the residues that give rise to nondegenerate chemical shifts
due to proline isomerization are shown in light gray and black
shading represents residues that are unaffected by proline isomer-
ization. The position of Pro 287 is indicated and the CD loop is
circled on each structure. The conformational change in the CD
loop that accompanies proline isomerization causes changes in the
solvent accessible surface area. (C) Superposition of the minimized
average cis and trans structures. (Backbone superposition was
carried for all residues excluding the CD loop (residues 278-290)).
Regions of conformational heterogeneity (CD, BG, and AB loops
and the tops of the central â-sheet and B helix) are highlighted in
orange (trans) and blue (cis). Regions of the protein which are
unaffected by proline isomerization are gray. The view of the
domain in panel C is rotated approximately 90° from that shown
in B.
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short peptide designed to approximate the unfolded state have
revealed significant differences (82). Specifically, the linear
peptide derived from the proline-containing loop in staphy-
lococcal nuclease is predominantly trans in solution, whereas
the same sequence adopts the cis form in the folded protein
(83). It is argued that noncovalent intramolecular forces
between the loop and the protein alter the cis/trans ratio and
serve to stabilize the cis form in that case (82). The examples
highlighted here all appear to conform to the same general
mechanism to achieve stabilization of dual imide bond
conformers.
There are particularly notable similarities between Itk and
MS2 at both the primary and secondary structural levels.
First, the proline residue in each case is located at the
carboxy-terminus of a loop that extends from two strands
of an antiparallel â-sheet. The position of proline at the base
of a loop and the physiochemical properties of the cross-
strand residue may be important components of the hinge
movement that results from isomerization. The Itk and MS2
loops themselves are close in size and share some sequence
similarity (Figure 7). In particular, a cluster of hydrophobic
residues occupy the central region of each loop (Val-Gly-
Gly-Val in MS2 and Ala-Ile-Ile in Itk). Itk and MS2 also
share a glutamate residue in the position directly preceding
the conformationally heterogeneous proline. Additionally, the
large conformational changes that occur upon proline
isomerization in both Itk (CD loop) and MS2 (FG loop) cause
smaller structural changes in the neighboring loops (AB and
BG loops of Itk SH2 (Figure 3C) and the AB and DE loops
of the MS2 protein (Figure 5C)). Of particular note is the
presence of multiple glycine residues in one of these proximal
loops in both proteins. For Itk, the BG loop contains three
consecutive glycines (Gly 326, Gly 327, and Gly 328) and
the AB loop of MS2 contains three nearly consecutive
glycine residues (Gly 13, Gly 14, and Gly 16). The flexibility
inherent to glycine containing sequences in close proximity
to a conformationally heterogeneous proline may be required
to accommodate the conformational change and maintain the
overall structure of the protein. The similarities between Itk
SH2 and the MS2 coat protein are striking and suggest there
may be characteristic structural and sequence motifs that
could serve as a signature for proline switches in native
proteins.
In support of this hypothesis, the zinc finger protein, Zpr1,
has recently been identified in a screen for cyclophilin A
dependent yeast strains (84). Amino acid mutations in Zpr1
were identified that confer cyclophilin A dependence on yeast
cells lacking cyclophilin A. Interestingly, two of the three
mutant alleles are identical and encode an amino change
directly preceding a conserved proline residue near the
carboxy-terminus of Zpr1 (84). The primary sequence in this
region of Zpr1 contains a similar pattern of amino acids as
already highlighted for Itk and MS2 (Figure 7). Namely,
Zpr1, like Itk and MS2, contains a cluster of hydrophobic
residues and a glutamate adjacent to the proline. High-
resolution structural data for Zpr1 is not yet available, and
so it is not possible to determine whether this region of Zpr1
may serve as a “proline switch” motif in the context of the
native protein. Nevertheless, the sequence similarities with
already characterized proline-containing sequences along
with the genetic evidence for a functional role for cyclophilin
A in regulating Zpr1 provide tantalizing hints that this region
of Zpr1 is functionally important and may contain a
conformationally heterogeneous proline residue.
FIGURE 4: (A) Solvent accessible surface of the Itk SH2 domain containing the trans imide bond at position 287. The residues for which
significant resonance frequency changes (>0.1 ppm 1H, >0.5 ppm 15N) are observed upon titration of the phosphopeptide (ADpYEPP) are
highlighted in yellow. Those residues that do not exhibit changes in resonance frequency upon peptide binding are orange. (B) The alternative
(cis) form of the SH2 domain binds in an intermolecular fashion to the conserved binding pocket of the Itk SH3 domain. For each protein
(cis SH2 and SH3), residues for which chemical shift perturbations are observed upon complex formation are shown in light yellow and
residues unaffected by the interaction are orange.
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NatiVe State Proline Isomerization Is Not Limited to Loop
Regions. TB Domain. One might expect that a conforma-
tionally heterogeneous proline would be located in a region
of relatively high flexibility in the context of a native fold
FIGURE 5: (A) The three monomeric subunits of the bacteriophage MS2 viral coat (pdb: 1ZDI) are chemically identical but differ with
respect to the imide bond conformation at position 78. (Pro 78 is highlighted in red for each monomer.) (B) The conformational differences
in the FG loop of subunit B (blue) are apparent in the superposition of the three subunits. (Backbone superposition was carried out for the
all residues excluding those of the FG loop.) Smaller structural differences are also apparent in this view for the DE loop. (C) Ribbon
representations of the subunits A and C (left) and subunit B (right). The FG loop containing the cis proline is bent 90° compared to the
same loop in the trans proline containing subunits A and C. Proline 78 and the preceding imide bond are shown in yellow. Thr 69 is labeled
and indicated in orange.
FIGURE 6: (A) Superposition of the “closed” (blue, pdb: 1TRH) and “open” (yellow, pdb: 1CRL) forms of C. rugosa lipase. The two
forms of the protein are identical outside of the conformationally heterogeneous loop region. (Regions of structural identity are shown in
cyan.) Backbone superposition was carried out for all residues excluding those of the loop (residues 66-92). (B) View of the “closed” loop
showing, in red, the cis prolyl residue at position 92 (red) and the corresponding hinge point at glutamate 66 (red). (C) Similar view of the
“open” form of the loop where Pro 92 (red) adopts the trans conformation. Glu 66 at the base of the loop is also shown in red.
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as opposed to the more stable regions of secondary structure
(56). While the three examples already discussed follow this
general rule, proline isomerization has been observed at least
in one case within the confines of stable secondary structure.
Structural analysis of the transforming growth factor â
binding protein-like (TB) domain from human fibrillin-1
reveals two stable conformers that differ with respect to the
isomerization state of two proline residues (Pro 22 and Pro
52) (85). Two structures of this protein were solved by NMR
spectroscopy corresponding to the major and minor forms
of the domain (Figure 8). In contrast to the examples
discussed above, the conformationally heterogeneous Pro 22
of the TB domain is embedded in a region of stable
secondary structure rather than a flexible loop region (Figure
8). In conjunction with the three-dimensional structures,
dynamics data provide further evidence that the polypeptide
region surrounding Pro 22 is well ordered for both conform-
ers. Despite the particular location of Pro 22, interconversion
between imide bond conformers occurs and causes measur-
able changes in the secondary structure topology of the
domain in the â-strands surrounding Pro 22 (Figure 8) (85).
While this example provides an alternative view into the
structural consequences of native state proline isomerization,
the functional significance of the major and minor forms of
the TB domain have yet to be elucidated. Certainly, the extent
of the observed structural perturbations that arise from proline
isomerization are on the order of those observed for the Itk
SH2 domain, and it is therefore conceivable that ligand
recognition by the TB domain could be directed by proline
isomerization in a similar manner.
The examples of native state proline isomerization dis-
cussed above point to the potentially general role of proline
as a molecular switch that can direct protein interactions by
altering a receptor binding surface. The unique properties
of proline, the energy barrier for interconversion between
the cis and trans forms and the potential for conformational
and dynamical differences between the two stable conforma-
tions, make this intrinsic switch ideal for conferring two
distinct, low energy structures to the overall native fold of a
protein. Continued structural analyses will illuminate the
mechanisms by which structural perturbations arising from
isomerization about a single imide bond are propagated
throughout a significant portion of a molecule. Such knowl-
edge should lead to an understanding of why some confor-
mationally heterogeneous proline residues cause very minor
local perturbations while others significantly alter the surface
binding properties of a protein. The elusive nature of proline
isomerization is a problem that will need to be addressed
before dramatic increases in the number of proteins exhibiting
native state isomerization will be realized. New experimental
approaches that are less demanding than NMR spectroscopy
and X-ray crystallography in terms of sample quantities and
instrumentation must be developed to facilitate identification
and analysis of native state proline isomerization. Along these
lines, the development of efficient, high throughput screens
for native state proline isomerization will be necessary to
fully characterize the extent to which this molecular switch
is at work within the ensemble of proteins that comprise the
cell.
Of the naturally occurring amino acids, proline is unique
and appears to fulfill multiple roles in the context of native,
folded proteins. In some proteins, proline isomerization may
confer conformer-specific properties to a native protein fold
by modulating the features of a protein surface. Alternatively,
a conformationally heterogeneous proline residue may cause
minimal structural perturbations but could instead serve as
a recognition site for a PPIase. Proline residues that exhibit
dual functionality with respect to these functions are also
likely to exist. In much the same way that mutation of
tyrosine to phenylalanine disrupts important phosphorylation
sites and abrogates signaling (86), it is possible that disease
states will be identified in the future that arise from mutation
of a functionally significant proline residue to an amino acid
that cannot access the cis conformation at a reasonable energy
FIGURE 7: Limited sequence comparison of the “proline-switch”
region of Itk with that of MS2 and a putative “proline-switch” of
Zpr1. The proline residue and a conserved glutamate (E) are
highlighted in red. A hydrophobic stretch (boxed) is present in each
sequence.
FIGURE 8: (A) Overlay of the 21 lowest energy solution structures of the major form of the TB domain (pdb: 1APJ). Pro 22 adopts the
trans conformation and Pro 52 adopts the cis conformation in this structure. The region of stable secondary structure (â-sheet) containing
Pro 22 is shown in yellow. Pro 52 (red) is located in a loop region outside of the defined secondary structure of the domain. (B) Same
representation as in panel A for the minor form of the TB domain where the proline conformers are inverted (Pro 22 (red) is cis and Pro
52 is trans). Isomerization of Pro 22 to the cis form disrupts the regular secondary structure in this region (remaining secondary structure
shown in yellow).
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cost. Thus, future efforts should strive to ascertain the extent
to which native-state proline isomerization is a general
control mechanism and simultaneously advance our funda-
mental understanding of the molecular basis for this intrinsic
conformational exchange process.
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